All‐trans‐retinoic acid ameliorates carbon tetrachloride‐induced liver fibrosis in mice through modulating cytokine production |
| |
Authors: | Shigeo Hisamori Chiharu Tabata Yoshio Kadokawa Kae Okoshi Rie Tabata Akira Mori Satoshi Nagayama Go Watanabe Hajime Kubo Yoshiharu Sakai |
| |
Institution: | 1. Department of Gastrointestinal Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan;2. *Contributed equally to this study.;3. Department of Internal Medicine, Respiratory Division, Hyogo College of Medicine, Hyogo, Japan;4. Department of Internal Medicine, Hyogo Prefectual Tsukaguchi Hospital, Hyogo, Japan |
| |
Abstract: | Background/Aims: Liver fibrosis with any aetiology, induced by the transdifferentiation and proliferation of hepatic stellate cells (HSCs) to produce collagen, is characterized by progressive worsening in liver function, leading to a high incidence of death. We have recently reported that all‐trans‐retinoic acid (ATRA) suppresses the transdifferentiation and proliferation of lung fibroblasts and prevents radiation‐ or bleomycin‐induced lung fibrosis. Methods: We examined the impact of ATRA on carbon tetrachloride (CCl4)‐induced liver fibrosis. We performed histological examinations and quantitative measurements of transforming growth factor (TGF)‐β1 and interleukin (IL)‐6 in CCl4‐treated mouse liver tissues with or without the administration of ATRA, and investigated the effect of ATRA on the production of the cytokines in quiescent and activated HSCs. Results: CCl4‐induced liver fibrosis was attenuated in histology by intraperitoneal administration of ATRA, and the overall survival rate at 12 weeks was 26.5% without ATRA (n=25), whereas it was 75.0% (n=24) in the treatment group (P=0.0187). In vitro studies disclosed that the administration of ATRA reduced (i) the production of TGF‐β1, IL‐6 and collagen from HSCs, (ii) TGF‐β‐dependent transdifferentiation of the cells and IL‐6‐dependent cell proliferation and (iii) the activities of nuclear factor‐κB p65 and p38mitogen‐activated protein kinase, which stimulate the production of TGF‐β1 and IL‐6, which could be the mechanism underlying the preventive effect of ATRA on liver fibrosis. Conclusions: Our findings indicate that ATRA ameliorates liver fibrosis. As the oral administration of the drug results in good compliance, ATRA could be a novel approach in the treatment of liver fibrosis. |
| |
Keywords: | α ‐smooth muscle actin all‐trans‐retinoic acid hepatic stellate cell interleukin‐6 liver fibrosis transforming growth factor‐β 1 |
|
|